Trump Administration Sued Over Executive Order Restricting Gender-Affirming Care for Trans Youth

The order blocks federal funding for providers offering gender-affirming treatments to individuals under 19, prompting legal challenges from families and advocacy groups.

President Trump's executive order directs federal agencies to withhold funding from medical providers offering gender-affirming care, including puberty blockers and hormone therapies, to individuals under 19.
Families of transgender youth, alongside advocacy organizations like the ACLU and Lambda Legal, have filed a federal lawsuit in Maryland, claiming the order is unconstitutional and discriminatory.
The order has already led some hospitals, including NYU Langone and VCU Health, to pause or cancel gender-affirming treatments for adolescent patients, creating widespread uncertainty and fear among families.
Major medical associations, including the American Academy of Pediatrics and the American Medical Association, consider gender-affirming care medically necessary and oppose governmental interference in doctor-patient relationships.
The lawsuit seeks immediate and permanent injunctions to block the enforcement of the order, emphasizing its potential to cause harm to transgender youth and their families.